ARCHIVES

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

This article is from The Cancer Letter archive.

Vol. 33 No. 07 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

Ten Is The New 12: Medicare Lowers Hemoglobin Targets For ESA Use.

August 3, 2007

Advisors tell NCI to rethink contracts for clinical trials cooperative group tissue banks

November 21, 2003

New Treatment Approaches For A Variety Of Leukemias Described At ASH Meeting

January 30, 2004

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005

Metastasis Research Is Example Of Progress Under 1971 Cancer Act

May 10, 1991

Charles Moertel, Mayo Clinic Investigator, Advocate Of Rigorous Trials, Dead At 66

July 8, 1994